Magnetic nanoparticles: recent developments in drug delivery system

References

• Tietze R, Zaloga J, Unterweger H, et al. Magnetic nanoparticle-based drug delivery for cancer therapy. Biochem Biophys Res Commun. 2015;468:463–470.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Sant S, Wang B, et al. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy. Adv Drug Deliv Rev. 2011;63:24–46.
   PubMed Web of Science ®Google Scholar
• Sun C, Lee JSH, Zhang MQ. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev. 2008;60:1252–1265.
   PubMed Web of Science ®Google Scholar
• Veiseh O, Gunn JW, Zhang MQ. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev. 2010;62:284–304.
   PubMed Web of Science ®Google Scholar
• Mody VV, Cox A, Shah S, et al. Magnetic nanoparticle drug delivery systems for targeting tumor. Appl Nanosci. 2014;4:385–392.
   Web of Science ®Google Scholar
• Park JH, Saravanakumar G, Kim K, et al. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev. 2010;62:28–41.
   PubMed Web of Science ®Google Scholar
• Alexiou C, Arnold W, Klein RJ, et al. Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 2000;60:6641–6648.
   PubMed Web of Science ®Google Scholar
• Senyei A, Widder K, Czerlinski G. Magnetic guidance of drug-carrying microspheres. J Appl Phys. 1978;49:3578–3583.
   Web of Science ®Google Scholar
• Mosbach K, Schroder U. Preparation and application of magnetic polymers for targeting of drugs. FEBS Lett. 1979;102:112–116.
   PubMed Web of Science ®Google Scholar
• Fang C, Kievit FM, Veiseh O, et al. Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach. J Control Release. 2012;162:233–241.
   PubMed Web of Science ®Google Scholar
• Assa F, Jafarizadeh-Malmiri H, Ajamein H, et al. Chitosan magnetic nanoparticles for drug delivery systems. Crit Rev Biotechnol. 2017;37:492.
   PubMed Web of Science ®Google Scholar
• Kohler N, Fryxell GE, Zhang M. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J Am Chem Soc. 2004;126:7206–7211.
   PubMed Web of Science ®Google Scholar
• Alegret N, Criado A, Prato M. Recent advances of graphene-based hybrids with magnetic nanoparticles for biomedical applications. Curr Med Chem. 2017;24:529.
   PubMed Web of Science ®Google Scholar
• Steitz B, Hofmann H, Kamau SW, et al. Characterization of PEI-coated superparamagnetic iron oxide nanoparticles for transfection: size distribution, colloidal properties and DNA interaction. J Magn Magn Mater. 2007;311:300–305.
   Web of Science ®Google Scholar
• Chorny M, Polyak B, Alferiev IS, et al. Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticles. FASEB J. 2007;21:2510–2519.
   PubMed Web of Science ®Google Scholar
• Park IK, Ng CP, Wang J, et al. Determination of nanoparticle vehicle unpackaging by MR imaging of a T-2 magnetic relaxation switch. Biomaterials. 2008;29:724–732.
   PubMed Web of Science ®Google Scholar
• Kim YS, Park IK, Kim WJ, et al. SPION nanoparticles as an efficient probe and carrier of DNA to umbilical cord blood-derived mesenchymal stem cells. J Nanosci Nanotech. 2011;11:1507–1510.
   PubMed Web of Science ®Google Scholar
• Wang J, Gong C, Wang Y, et al. Magnetic nanoparticles with a pH-sheddable layer for antitumor drug delivery. Colloids Surf B Biointerfaces. 2014;118:218.
   PubMed Web of Science ®Google Scholar
• Ding Y, Shen SZ, Sun H, et al. Design and construction of polymerized-chitosan coated Fe3O4 magnetic nanoparticles and its application for hydrophobic drug delivery. Mater Sci Eng C Mater Biol Appl. 2015;48:487.
   PubMed Web of Science ®Google Scholar
• Singh A, Dilnawaz F, Mewar S, et al. Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. ACS Appl MaterInterfaces. 2014;6:4595.
   PubMed Web of Science ®Google Scholar
• Gunn J, Wallen H, Veiseh O, et al. A multimodal targeting nanoparticle for selectively labeling T cells. Small. 2008;4:712–715.
   PubMed Web of Science ®Google Scholar
• Pan D, Caruthers SD, Hu G, et al. Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance Imaging of vascular targets. J Am Chem Soc. 2008;130:9186–9187.
   PubMed Web of Science ®Google Scholar
• Khirwadkar P, Kumar V, Dashora K. Magnetic nanoparticles for drug delivery. Indo Am J Pharm Res. 2014;4:5599–5610.
   Google Scholar
• Leo E, Angela Vandelli M, Cameroni R, et al. Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: involvement of the drug in the cross-linking process. Int J Pharm. 1997;155:75–82.
   Web of Science ®Google Scholar
• Tian J, Yan C, Liu K, et al. Paclitaxel loaded magnetic nanoparticles: synthesis, characterization and application in targeting. J Pharm Sci. 2017;106:2115–2122.
   PubMed Web of Science ®Google Scholar
• Yu S, Wu G, Gu X, et al. Magnetic and pH-sensitive nanoparticles for antitumor drug delivery. Colloids Surf B Biointerfaces. 2013;103:15–22.
   PubMed Web of Science ®Google Scholar
• Taresco V, Francolini I, Padella F, et al. Design and characterization of antimicrobial usnic acid loaded-core/shell magnetic nanoparticles. Mater Sci Eng C Mater Biol Appl. 2015;52:72.
   PubMed Web of Science ®Google Scholar
• Cheng K, Sun Z, Zhou Y, et al. Preparation and biological characterization of hollow magnetic Fe3O4@C nanoparticles as drug carriers with high drug loading capability, pH-control drug release and MRI properties. Biomater Sci. 2013;1:965–974.
   Web of Science ®Google Scholar
• Xiong F, Tian J, Hu K, et al. Superparamagnetic anisotropic nano-assemblies with longer blood circulation in vivo: a highly efficient drug delivery carrier for leukemia therapy. Nanoscale. 2016;8:17085–17089.
   PubMed Web of Science ®Google Scholar
• Ling D, Lee N, Hyeon T. Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications. Acc Chem Res. 2015;48:1276–1285.
   PubMed Web of Science ®Google Scholar
• Stephen ZR, Kievit FM, Zhang MQ. Magnetite nanoparticles for medical MR imaging. Mater Today (Kidlington). 2011;14:330–338.
   PubMedGoogle Scholar
• Shubayev VI, Pisanic TR, Jin SH. Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev. 2009;61:467–477.
   PubMed Web of Science ®Google Scholar
• Kim M, Jung J, Lee J, et al. Amphiphilic comblike polymers enhance the colloidal stability of Fe3O4 nanoparticles. Colloids Surf B Biointerfaces. 2010;76:236–240.
   PubMed Web of Science ®Google Scholar
• Puscasu E, Nadejde C, Creanga D, et al. Stable colloidal suspension of magnetic nanoparticles for applications in life sciences. Mater Today Proceed. 2015;2:3813–3818.
   Google Scholar
• Soenen SJ, De CM. Assessing iron oxide nanoparticle toxicity in vitro: current status and future prospects. Nanomedicine. 2010;5:1261–1275.
   PubMed Web of Science ®Google Scholar
• Kunzmann A, Andersson B, Thurnherr T, et al. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta. 2011;1810:361–373.
   PubMed Web of Science ®Google Scholar
• Arruebo M, Fernández-Pacheco R, Ibarra MR, et al. Magnetic nanoparticles for drug delivery. Nano Today. 2007;2:22–32.
   Web of Science ®Google Scholar
• Li M, Kim HS, Tian L, et al. Comparison of two ultrasmall superparamagnetic iron oxides on cytotoxicity and MR imaging of tumors. Theranostics. 2012;2:76.
   PubMed Web of Science ®Google Scholar
• Sharifi S, Behzadi S, Laurent S, et al. Toxicity of nanomaterials. Chem Soc Rev. 2012;41:2323.
   PubMed Web of Science ®Google Scholar
• Soenen SJH, Cuyper MD. Assessing cytotoxicity of (iron oxide-based) nanoparticles: an overview of different methods exemplified with cationic magnetoliposomes. Contrast Media Mol Imaging. 2009;4:207–219.
   PubMed Web of Science ®Google Scholar
• Soenen SJH, Himmelreich U, Nuytten N, et al. Cytotoxic effects of iron oxide nanoparticles and implications for safety in cell labelling. Biomaterials. 2011;32:195.
   PubMed Web of Science ®Google Scholar
• Bernd H, De Kerviler E, Gaillard S, et al. Safety and tolerability of ultrasmall superparamagnetic iron oxide contrast agent: comprehensive analysis of a clinical development program. Invest Radiol. 2009;44:336–342.
   PubMed Web of Science ®Google Scholar
• Shevtsov MA, Yakovleva LY, Nikolaev BP, et al. Tumor targeting using magnetic nanoparticle Hsp70 conjugate in a model of C6 glioma. Neuro Oncol. 2014;16:38–49.
   PubMed Web of Science ®Google Scholar
• Al FA, Shaik AP, Shaik AS. Magnetic single-walled carbon nanotubes as efficient drug delivery nanocarriers in breast cancer murine model: noninvasive monitoring using diffusion-weighted magnetic resonance imaging as sensitive imaging biomarker. Int J Nanomed. 2015;10:157–168.
   PubMed Web of Science ®Google Scholar
• Andresen TL, Jensen SS, Jorgensen K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res. 2005;44:68–97.
   PubMed Web of Science ®Google Scholar
• Li M, Zhao C, Yang X, et al. In situ monitoring Alzheimer’s disease β-amyloid aggregation and screening of Aβ inhibitors using a perylene probe. Small. 2013;9:52–55.
   PubMed Web of Science ®Google Scholar
• Hauser AK, Wydra RJ, Stocke NA, et al. Magnetic nanoparticles and nanocomposites for remote controlled therapies. J Control Release. 2015;219:76–94.
   PubMed Web of Science ®Google Scholar
• Reddy LH, Arias JL, Nicolas J, et al. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev. 2012;112:5818.
   PubMed Web of Science ®Google Scholar
• Liu T-Y, Hu S-H, Liu D-M, et al. Biomedical nanoparticle carriers with combined thermal and magnetic responses. Nano Today. 2009;4:52–65.
   Web of Science ®Google Scholar
• Wu F, Li Q, Zhang X, et al. Fabrication and characterization of thermo-sensitive magnetic polymer composite nanoparticles. J Magn Magn Mater. 2012;324:1326–1330.
   Web of Science ®Google Scholar
• Geng Y, Dalhaimer P, Cai S, et al. Shape effects of filaments versus spherical particles in flow and drug delivery. Nature Nanotech. 2007;2:249.
   PubMed Web of Science ®Google Scholar
• Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug delivery. J Drug Target. 2016;24:179.
   PubMed Web of Science ®Google Scholar
• Okuhata Y. Delivery of diagnostic agents for magnetic resonance imaging. Adv Drug Deliv Rev. 1999;37:121.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Hosseinkhani H, Hosseinkhani M, et al. Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chem Rev. 2011;111:253–280.
   PubMed Web of Science ®Google Scholar
• Soenen SJH, De Cuyper M. How to assess cytotoxicity of (iron oxide-based) nanoparticles. A technical note using cationic magnetoliposomes. Contrast Media Mol Imaging. 2011;6:153–164.
   PubMed Web of Science ®Google Scholar
• Shen M, Cai H, Wang X, et al. Facile one-pot preparation, surface functionalization, and toxicity assay of APTS-coated iron oxide nanoparticles. Nanotechnology. 2012;23:105601.
   PubMed Web of Science ®Google Scholar
• Kedziorek DA, Muja N, Walczak P, et al. Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles. Magn Reson Med. 2010;63:1031–1043.
   PubMed Web of Science ®Google Scholar
• Singh N, Jenkins GJS, Asadi R, et al. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 2010;1:10.
   Google Scholar
• Buyukhatipoglu K, Clyne AM. Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation. J Biomed Mater Res A. 2011;96:186–195.
   PubMed Web of Science ®Google Scholar
• Naqvi S, Samim M, Abdin M, et al. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int J Nanomed. 2010;5:983.
   PubMed Web of Science ®Google Scholar
• Soenen SJH, Illyes E, Vercauteren D, et al. The role of nanoparticle concentration-dependent induction of cellular stress in the internalization of non-toxic cationic magnetoliposomes. Biomaterials. 2009;30:6803–6813.
   PubMed Web of Science ®Google Scholar
• Jiang W, Kim BYS, Rutka JT, et al. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol. 2008;3:145.
   PubMed Web of Science ®Google Scholar
• Kunzmann A, Andersson B, Vogt C, et al. Efficient internalization of silica-coated iron oxide nanoparticles of different sizes by primary human macrophages and dendritic cells. Toxicol Appl Pharmacol. 2011;253:81–93.
   PubMed Web of Science ®Google Scholar
• Shen CC, Wang CC, Liao MH, et al. A single exposure to iron oxide nanoparticles attenuates antigen-specific antibody production and T-cell reactivity in ovalbumin-sensitized BALB/c mice. Int J Nanomed. 2011;6:1229–1235.
   PubMed Web of Science ®Google Scholar
• Schlachter EK, Widmer HR, Bregy A, et al. Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study. Int J Nanomed. 2011;6:1793–1800.
   PubMed Web of Science ®Google Scholar
• Malindretos P, Sarafidis PA, Rudenco I, et al. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran. Am J Nephrol. 2007;27:572–579.
   PubMed Web of Science ®Google Scholar
• Anzai Y, Piccoli CW, Outwater EK, et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology. 2003;228:777–788.
   PubMed Web of Science ®Google Scholar
• Almeida JPM, Chen AL, Foster A, et al. In vivo biodistribution of nanoparticles. Nanomedicine (Lond). 2011;6:815.
   PubMed Web of Science ®Google Scholar
• Kim JE, Shin JY, Cho MH. Magnetic nanoparticles: an update of application for drug delivery and possible toxic effects. Arch Toxicol. 2012;86:685–700.
   PubMed Web of Science ®Google Scholar
• Sasidharan A, Panchakarla LS, Sadanandan AR, et al. Hemocompatibility and macrophage response of pristine and functionalized graphene. Small. 2012;8:1251–1263.
   PubMed Web of Science ®Google Scholar
• Xie J, Chen K, Huang J, et al. PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials. 2010;31:3016.
   PubMed Web of Science ®Google Scholar
• Fischer HC, Chan WC. Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol. 2007;18:565.
   PubMed Web of Science ®Google Scholar
• Gu L, Fang RH, Sailor MJ, et al. In vivo clearance and toxicity of monodisperse iron oxide nanocrystals. ACS Nano. 2012;6:4947–4954.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li M, Yang F, et al. Magnetic drug delivery systems. Sci China Mater. 2017;60:471–486.
   Web of Science ®Google Scholar
• Tartaj P, Morales MP, González-Carreño T, et al. Advances in magnetic nanoparticles for biotechnology applications. J Magn Magn Mater. 2005;290–291:28–34.
   Web of Science ®Google Scholar
• Sun Y, Lin H, Yu C, et al. Research progress in nanoparticles as anticancer drug carrier. Chin J Clin Oncol. 2014;10:489–493.
   Google Scholar
• Vasir JK, Reddy MK, Labhasetwar VD. Nanosystems in drug targeting: opportunities and challenges. Curr Nanosci. 2005;1:47–64.
   Web of Science ®Google Scholar
• Iyer AK, Khaled G, Fang J, et al. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today. 2006;11:812–818.
   PubMed Web of Science ®Google Scholar
• Shuhendler AJ, Prasad P, Leung M, et al. A novel solid lipid nanoparticle formulation for active targeting to tumor alpha(v)beta(3) integrin receptors reveals cyclic RGD as a double-edged sword. Adv Healthc Mater. 2012;1:600–608.
   PubMed Web of Science ®Google Scholar
• Maeda H, Sawa T, Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release. 2001;74:47–61.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2001;73:137–172.
   PubMed Web of Science ®Google Scholar
• Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul. 2001;41:189–207.
   PubMedGoogle Scholar
• Greish K. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target. 2007;15:457–464.
   PubMed Web of Science ®Google Scholar
• Nishioka Y, Yoshino H. Lymphatic targeting with nanoparticulate system. Adv Drug Deliv Rev. 2001;47:55–64.
   PubMed Web of Science ®Google Scholar